Search company, investor...

Predict your next investment

Corporation
Remesys.com.au

Portfolio Exits

1

About Remesys

Remesys is an Australian remuneration and talent management software provider specializing in remuneration review and performance management software.

Headquarters Location

189 Kent Street Suite 5, Level 2

Sydney, New South Wales, 2000,

Australia

+61 2 9247 7277

Want to inform investors similar to Remesys about your company?

Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.

Remesys Portfolio Exits

1 Portfolio Exit

Remesys has 1 portfolio exit. Their latest portfolio exit was Pivot Software on February 27, 2018.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

2/27/2018

Acquired

$99M

1

Date

2/27/2018

Exit

Acquired

Companies

Valuation

$99M

Acquirer

Sources

1

Remesys Acquisitions

1 Acquisition

Remesys acquired 1 company. Their latest acquisition was Pivot Software on November 29, 2016.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

11/29/2016

$99M

Merger

1

Date

11/29/2016

Investment Stage

Companies

Valuation

$99M

Total Funding

Note

Merger

Sources

1

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.